API
Hovione inhalation grade APIs bring unique controlled performance to your formulation.
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione inhalation grade APIs bring unique controlled performance to your formulation.
Pharmaceutical Technology Europe, June 2007
Carla Vozone and Manuel Lourenço look at Simvastatin as a case study in the supply of off-patent API
EP Certificates - Granted by EDQM
Learn more about Hovione portfolio of API for Inhalation
Hovione receives Global the Generics & Biosimilars Award 2016 in the category of API Supplier of the Year.
News release, 18 February 2022
Hovione and CyDex, today announced an alliance to develop and commercialize improved formulations of drugs that are off-patent or soon will be off-patent.